Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Class III · Low risk

Distributed by: DocRx

Labeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.

Ongoing Labeling / mix-up Asclemed USA Inc. dba Enovachem Pharmaceuticals D-0330-2021
Class II · Moderate risk

Neomycin Sulfate Tablets

Failed Stability Specifications: Out of Specification (OOS) result reported for microbiological assay

Terminated Stability / shelf life X-Gen Pharmaceuticals Inc. NDC 39822-0310-5 D-0328-2021
Class II · Moderate risk

Omeprazole Delayed Release Capsules

Failed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturer

Terminated Impurity / degradation Golden State Medical Supply Inc. NDC 51407-129-10 D-0312-2021
Class III · Low risk

Lcl-2-0191

An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.

Terminated Other Washington Homeopathic Products, Inc. D-0323-2021
Class III · Low risk

Sp-4

An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.

Terminated Other Washington Homeopathic Products, Inc. D-0322-2021
Class III · Low risk

Macula Pellets Homeopathic Medicine

An error occurred where the product was manufactured with Potassium Chloride instead of Potassium Phosphate.

Terminated Other Washington Homeopathic Products, Inc. NDC 58770-190-42 D-0321-2021
Class II · Moderate risk

Brompheniramine Maleate

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 60432-275-16 D-0596-2021
Class II · Moderate risk

Briviact (brivaracetam)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 50474-570-66 D-0591-2021
Class II · Moderate risk

VIMPAT (lacosamide)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0131-2480-35 D-0590-2021
Class II · Moderate risk

VIMPAT (lacosamide)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. D-0589-2021
Class II · Moderate risk

Sulindac Tablets

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 42806-011-01 D-0582-2021

Recalls by year